# Paclitaxel

NDC: 0703-3218
Generic name: Paclitaxel
Labeler / Manufacturer: Teva Parenteral Medicines, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20200305

FDA application: ANDA075184

## Active ingredients

- PACLITAXEL: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0703-3218"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0703-3218
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4be6cbf-72b9-4f7f-9b1b-459b2d35961a